| 1 | 1573274 | Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase. | J Immunol | 1992 May 1 |
5 |
| 2 | 2378872 | Dog mast cell chymase: molecular cloning and characterization. | Biochemistry | 1990 May 29 |
2 |
| 3 | 2384602 | Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs. | J Clin Invest | 1990 Aug |
10 |
| 4 | 2494259 | Mast cell chymase. A potent secretagogue for airway gland serous cells. | J Immunol | 1989 Apr 1 |
9 |
| 5 | 2504277 | Molecular cloning of dog mast cell tryptase and a related protease: structural evidence of a unique mode of serine protease activation. | Biochemistry | 1989 May 16 |
1 |
| 6 | 3118812 | Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence. | Arch Biochem Biophys | 1987 Nov 1 |
2 |
| 7 | 7768912 | Purification and characterization of dog mast cell protease-3, an oligomeric relative of tryptases. | J Biol Chem | 1995 Jun 2 |
2 |
| 8 | 9379034 | Cloning and expression of the dog mast cell alpha-chymase gene. | J Immunol | 1997 Nov 1 |
1 |
| 9 | 10361885 | Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog. | Jpn J Pharmacol | 1999 Apr |
1 |
| 10 | 10899625 | Angiotensin II generation by mast cell alpha- and beta-chymases. | Biochim Biophys Acta | 2000 Jul 14 |
3 |
| 11 | 11551879 | Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation. | Circulation | 2001 Sep 11 |
1 |
| 12 | 11665834 | Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein. | Life Sci | 2001 Aug 31 |
3 |
| 13 | 12105135 | Differential regulation of elevated renal angiotensin II in chronic renal ischemia. | Hypertension | 2002 Jul |
1 |
| 14 | 12499575 | Development of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities. | Jpn J Pharmacol | 2002 Nov |
1 |
| 15 | 12931253 | Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation. | Cardiovasc Drug Rev | 2003 Fall |
2 |
| 16 | 14730006 | An antiarrhythmic effect of a chymase inhibitor after myocardial infarction. | J Pharmacol Exp Ther | 2004 May |
1 |
| 17 | 15107585 | A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins. | J Pharmacol Sci | 2004 Apr |
4 |
| 18 | 17460374 | The effects of chymase on matrix metalloproteinase-2 activation in neointimal hyperplasia after balloon injury in dogs. | Hypertens Res | 2007 Jan |
2 |
| 19 | 17541214 | The significance of chymase in the progression of abdominal aortic aneurysms in dogs. | Hypertens Res | 2007 Apr |
1 |
| 20 | 17920080 | Roles of chymase in stenosis occurring after polytetrafluoroethylene graft implantations. | Life Sci | 2007 Sep 29 |
3 |